News

Accelerating Drug Development: FDA's AI Clinical Trials RFI Guide

FDA · 6 min

Formycon AG Geschäftsbericht 2025: Key Insights and Implications

FDA · 7 min

FDA's Permanent Ban on Compounded GLP-1s: What It Means for Pharma

FDA · GLP-1 · 3 min

2025 Drug Approvals: Biopharma's Resilience Amidst Challenges

FDA · 2 min

FDA Considers Easing Restrictions on Unproven Peptides

FDA · 2 min

FDA Approvals in Oncology: January-March 2026

FDA · oncology · 3 min

US FDA Proposes New Regulations on Weight-Loss Drug Compounding

FDA · weight loss · 2 min

Eli Lilly Acquires Centessa Pharmaceuticals: Market Analysis

3 min

FDA Eases Restrictions on Peptides: Implications for Drug Approvals

FDA · 2 min

FDA Considers Adding Peptides to Bulk Drug Compounding List

FDA · 2 min

Sunlight GLP-1 2026: FDA's Decision on Compounded Semaglutide

FDA · GLP-1 · 3 min

Top Biotech Gainers: CODX, NRXP, NVAX - Clinical Trials Update

FDA · Ebola · 3 min